Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

6.01
Delayed Data
As of 3:59pm ET
 +0.26 / +4.52%
Today’s Change
3.07
Today|||52-Week Range
9.36
-2.28%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$344.8M

Company Description

Arrowhead Pharmaceuticals, Inc. engages as a biopharmaceutical company developing targeted RNAi therapeutics. Its pipeline includes clinical programs in chronic hepatitis B virus and partner based programs in obesity and oncology. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Contact Information

Arrowhead Pharmaceuticals, Inc.
225 South Lake Avenue
Pasadena California 91101-3009
P:(626) 304-3400
Investor Relations:

Employees

Shareholders

Mutual fund holders19.85%
Other institutional14.79%
Individual stakeholders1.88%

Top Executives

Christopher Richard AnzalonePresident, Chief Executive Officer & Director
Bruce D. GivenChief Operating Officer
Kenneth Allen MyszkowskiChief Financial Officer
David LewisChief Scientific Officer
Vince AnzaloneVice President-Investor Relations